Merz Aesthetics
Medical Equipment Manufacturing1001-5000 Employees
Merz Aesthetics operates in the medical equipment manufacturing sector, focusing on products for aesthetic medicine. Its offerings include injectable treatments and devices used by clinics and medical partners to perform cosmetic procedures, with recent launches such as Xeomin and Radiesse in China and Ultherapy PRIME introduced at the end of 2024. These actions indicate an emphasis on expanding its global footprint within the aesthetics market. The company serves medical clinics and partner networks in aesthetic medicine seeking proven solutions for cosmetic treatments and patient safety. Its activities span global markets, including China, as shown by regional launches. The materials reference a 2016 plan to consolidate its LinkedIn presence under the Merz Pharmaceuticals brand, and they do not provide headquarters or founding details.